PSI
CRL icon

Planning Strategies Inc.’s Charles River Laboratories CRL Stock Holding History

Planning Strategies Inc.’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Buy
+8
New +$1.43K ﹤0.01% 614

Other funds holding CRL

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Planning Strategies Inc.'s CRL Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Charles River Laboratories (CRL) in Q2 2026: 8 shares worth $1.81K. The stake represents ﹤0.01% of the portfolio and ranks #614 among its holdings.

150 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Planning Strategies Inc. held 8 shares of Charles River Laboratories worth $1.81K as of Q2 2026.
  • Charles River Laboratories was a new Planning Strategies Inc. position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #614 holding.
  • 150 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.